Achalasie und Ösophagusmotilitätsstörungen

Funktionseinschränkungen bzw. Motilitätsstörungen der Speiseröhre sollten bei der Abklärung dysphagischer Beschwerden und nicht kardialer Brustschmerzen stets in Betracht gezogen werden. Die Achalasie ist die am besten definierte primäre Motilitätsstörung der Speiseröhre – ihre 3 klinisch relevanten Subtypen werden in diesem Beitrag näher beleuchtet. Im Anschluss werden weitere klinisch relevante Motilitätsstörungen des Ösophagus vorgestellt.

Schlüsselwörter

Achalasie - Jackhammer-Ösophagus - nicht kardialer Thoraxschmerz - hochauflösende Manometrie - POEM

• Literatur

• 1 Boeckxstaens GE, Zaninotto G, Richter JE. Achalasia. Lancet 2014; 383: 83-93
• 2 Zaninotto G, Bennett C, Boeckxstaens G. et al. The 2018 ISDE achalasia guidelines. Dis Esophagus 2018;
• 3 Gockel I, Becker J, Wouters MM. et al. Common variants in the HLA-DQ region confer susceptibility to idiopathic achalasia. Nat Genet 2014; 46: 901-904
• 4 Ponds FA, van Raath MI, Mohamed SMM. et al. Diagnostic features of malignancy associated pseudoachalasia. Aliment Pharmacol Ther 2017; 45: 1449-1458
• 5 Tsuboi K, Hoshino M, Srinivasan A. et al. Insight gained from symptom evaluation of esophageal motility disorders: a review of 4,215 patients. Digestion 2012; 85: 236-242
• 6 Eckardt VF. Clinical presentations and complications of achalasia. Gastrointest Endosc Clin N Am 2001; 11: 281-292
• 7 Eckardt VF, Stauf B, Bernhard G. Chest pain in achalasia: patients characteristics and clinical course. Gastroenterology 1999; 116: 1300-1304
• 8 Rohof WO, Salvador R, Annese V. et al. Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology 2013; 144: 718-725
• 9 Roman S, Huot L, Zerbib E. et al. High-resolution manometry improves the diagnosis of esophageal motility disorders in patients with dysphagia: A randomized multicenter study. Am J Gastroenterol 2016; 111: 372-380
• 10 Keller J, Fox MR, Allescher HD. et al. Interpretation und Durchführung der hochauflösenden Ösophagusmanometrie: Empfehlungen der DGNM sowie der DGVS. Z Gastroenterol 2018; 56: 1378-1408
• 11 Kahrilas PJ, Bredenoord AJ, Fox M. et al. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil 2015; 27: 160-174
• 12 Pandolfino JE, Kwiatek MA, Nealis T. et al. Achalasia: a new clinically relevant classification by high-resolution manometry. Gastroenterology 2008; 135: 1526-1533
• 13 Rohof WO, Lei A, Boeckxstaens GE. et al. Esophageal stasis on a timed barium esophagogram predicts recurrent symptoms in patients with long-standing achalasia. Am J Gastroenterol 2013; 108: 49-55
• 14 Ponds FA, Moonen A, Smout AJPM. et al. Screening for dysplasia with Lugol chromoendoscopy in longstanding idiopathic achalasia. Am J Gastroenterol 2018; 113: 855-862
• 15 Vaezi MF, Richter JE, Wilcox CM. et al. Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut 1999; 44: 231-239
• 16 Zaninotto G, Annese V, Costantini M. et al. Randomized controlled trial of botulinum toxin versus laparoscopic heller myotomy for esophageal achalasia. Ann Surg 2004; 239: 364-370
• 17 Boeckxstaens GE, Annese V, des Varannes SB. et al. Pneumatic dilatation versus laparoscopic Hellerʼs myotomy for idiopathic achalasia. N Engl J Med 2011; 364: 1807-1816
• 18 Moonen A, Annese V, Belmans A. et al. Long-term results of the European achalasia trial: a multicentre randomised controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy. Gut 2016; 65: 732-739
• 19 Hulselmans M, Vanuytsel T, Degreef T. et al. Long-term outcome of pneumatic dilation in the treatment of achalasia. Clin Gastroenterol Hepatol 2010; 8: 30-35
• 20 Zerbib F, Thétiot V, Richy F. et al. Repeated pneumatic dilations as long-term maintenance therapy for esophageal achalasia. Am J Gastroenterol 2006; 101: 692-697
• 21 Inoue H, Minami H, Kobayashi Y. et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy 2010; 42: 265-271
• 22 Li QL, Wu QN, Zhang XC. et al. Outcomes of per-oral endoscopic myotomy for treatment of esophageal achalasia with a median follow-up of 49 months. Gastrointest Endosc 2018; 87: 1405-1412
• 23 Teitelbaum EN, Dunst CM, Reavis KM. et al. Clinical outcomes five years after POEM for treatment of primary esophageal motility disorders. Surg Endosc 2018; 32: 421-427
• 24 Werner YB, Costamagna G, Swanström LL. et al. Clinical response to peroral endoscopic myotomy in patients with idiopathic achalasia at a minimum follow-up of 2 years. Gut 2016; 65: 899-906
• 25 Von Renteln D, Fuchs KH, Fockens P. et al. Peroral endoscopic myotomy for the treatment of achalasia: an international prospective multicenter study. Gastroenterology 2013; 145: 309-311
• 26 Ponds FA, Fockens P, Neuhaus H. et al. Peroral endoscopic myotomy (POEM) versus pneumatic dilatation in therapy-naive patients with achalasia: results of a randomized controlled trial. Gastroenterology 2017; 152 (Suppl. 01) S139
• 27 Werner YB, Hakanson B, Martinek J. et al. Endoscopic versus surgical myotomy in patients with primary achalasia. United European Gastroenterol J 2018; 6: S1590
• 28 Zaninotto G, Costantini M, Rizzetto C. et al. Four hundred laparoscopic myotomies for esophageal achalasia: a single centre experience. Ann Surg 2008; 248: 986-993
• 29 Tyberg A, Sharaiha RZ, Familiari P. et al. Peroral endoscopic myotomy as salvation technique post-Heller: Intermational experience. Dig Endosc 2018; 30: 52-56
• 30 Roman S, Pandolfino JE, Chen J. et al. Phenotypes and clinical context of hypercontractility on high-resolution esophageal pressure topography (EPT). Am J Gastroenterol 2012; 107: 37-45
• 31 Herregods TV, Smout AJ, Ooi JL. et al. Jackhammer esophagus: Observations on a European cohort. Neurogastroenterol Motil 2017;
• 32 Tack J, Zaninotto G. Therapeutic options in oesophageal dysphagia. Nat Rev Gastroenterol Hepatol 2015; 12: 332-341
• 33 Vanuytsel T, Bisschops R, Farré R. et al. Botulinum toxin reduces dysphagia in patients with nonachalasia primary esophageal motility disorders. Clin Gastroenterol Hepatol 2013; 11: 1115-1121
• 34 Khashab MA, Benias PC, Swanström LL. Endoscopic myotomy for foregut motility disorders. Gastroenterology 2018; 154: 1901-1910
• 35 Filicori F, Dunst CM, Sharata A. et al. Long-term outcomes following POEM for non-achalasia motility disorders of the esophagus. Surg Endosc 2018;
• 36 Albers D, Frieling T, Dakkak D. et al. Peroral endoscopic myotomy (POEM) is effective in treatment of noncardiac chest pain caused by hypercontractile esophageal motility disorders: results of the POEM-HYPE-Study. Z Gastroenterol 2018; 56: 1337-1342